Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Albireo Pharma, Inc. (ALBO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
27.14+1.41 (+5.48%)
At close: 04:00PM EST
27.14 0.00 (0.00%)
After hours: 07:23PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/17/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.41
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 343.41
52 Week Low 320.30
50-Day Moving Average 324.80
200-Day Moving Average 329.75

Share Statistics

Avg Vol (3 month) 3177.06k
Avg Vol (10 day) 3253.31k
Shares Outstanding 519.28M
Implied Shares Outstanding 6N/A
Float 816.8M
% Held by Insiders 10.45%
% Held by Institutions 185.59%
Shares Short (Dec 14, 2021) 41.15M
Short Ratio (Dec 14, 2021) 46.41
Short % of Float (Dec 14, 2021) 48.04%
Short % of Shares Outstanding (Dec 14, 2021) 45.99%
Shares Short (prior month Nov 14, 2021) 41.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 03, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Nov 03, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,122.74%

Management Effectiveness

Return on Assets (ttm)-24.89%
Return on Equity (ttm)-24.33%

Income Statement

Revenue (ttm)10.77M
Revenue Per Share (ttm)0.56
Quarterly Revenue Growth (yoy)71.90%
Gross Profit (ttm)8.31M
EBITDA -120.72M
Net Income Avi to Common (ttm)-47.87M
Diluted EPS (ttm)-2.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)262.61M
Total Cash Per Share (mrq)13.62
Total Debt (mrq)13.07M
Total Debt/Equity (mrq)7.19
Current Ratio (mrq)8.20
Book Value Per Share (mrq)9.43

Cash Flow Statement

Operating Cash Flow (ttm)-121.86M
Levered Free Cash Flow (ttm)-54.74M
Advertisement
Advertisement